Cecum neuroendocrine tumor G1

MONDO:0006126

A well differentiated, low grade neuroendocrine tumor (carcinoid tumor) that arises from the cecum. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent.

Also known as: caecal carcinoid tumor, caecal carcinoid tumour, caecum NET G1, caecum carcinoid tumor, caecum carcinoid tumor (disease), caecum carcinoid tumour, caecum carcinoid tumour (disease), caecum neuroendocrine neoplasm G1

1494 clinical trials for this condition and its sub-types, 3 tagged with Cecum neuroendocrine tumor G1 itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Cecal neoplasm (59) ↑ Colon neuroendocrine tumor G1 (3)

Sub-types of Cecum neuroendocrine tumor G1

Appendix neuroendocrine tumor G1 0 trials

Including sub-types (1494) Tagged with Cecum neuroendocrine tumor G1 (3)

Trials to join now! 2 Completed 1

New pill could ease carcinoid syndrome Flare-Ups

Symptom relief Completed

This Phase 2 trial tested paltusotine, an oral drug, in 36 adults with carcinoid syndrome. The study looked at safety and how the body processes the drug at different doses. Participants were randomly assigned to 40 mg or 80 mg daily, with dose adjustments allowed. The goal is to…

Phase 2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 11:02 UTC

Cecum neuroendocrine tumor G1

Where it sits in the disease tree

New pill could ease carcinoid syndrome Flare-Ups